Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 850

1.

A Bayesian gene network reveals insight into the JAK-STAT pathway in systemic lupus erythematosus.

Li Y, Higgs RE, Hoffman RW, Dow ER, Liu X, Petri M, Wallace DJ, Dörner T, Eastwood BJ, Miller BB, Liu Y.

PLoS One. 2019 Dec 2;14(12):e0225651. doi: 10.1371/journal.pone.0225651. eCollection 2019.

2.

Anti-retinoblastoma Protein Antibodies: A New Specificity in Systemic Lupus Erythematosus Associated With Protection Against Lupus Nephritis.

Goules A, Li J, Antiochos B, Goldman DW, Rosen A, Petri M, Casciola-Rosen L.

ACR Open Rheumatol. 2019 Jun 6;1(5):287-291. doi: 10.1002/acr2.1036. eCollection 2019 Jul.

3.

Development of a systemic lupus erythematosus cardiovascular risk equation.

Petri MA, Barr E, Magder LS.

Lupus Sci Med. 2019 Oct 10;6(1):e000346. doi: 10.1136/lupus-2019-000346. eCollection 2019.

4.

Rare Germline Mutations in Complement Regulatory Genes Make the Antiphospholipid Syndrome Catastrophic.

Chaturvedi S, Braunstein EM, Yuan X, Chen H, Alluri RK, Streiff MB, Petri M, Crowther M, McCrae KR, Brodsky RA.

Blood. 2019 Nov 13;134(Supplement_1):4. doi: 10.1182/blood-2019-129115.

PMID:
31724011
5.

Association of African-American ethnicity and smoking status with total and individual damage index in systemic lupus erythematosus.

Kallas R, Li J, Petri M.

Clin Rheumatol. 2019 Nov 8. doi: 10.1007/s10067-019-04800-1. [Epub ahead of print]

PMID:
31705325
6.

Predictors of predominant Lupus Low Disease Activity State (LLDAS-50).

Babaoglu H, Li J, Goldman D, Magder LS, Petri M.

Lupus. 2019 Dec;28(14):1648-1655. doi: 10.1177/0961203319886028. Epub 2019 Nov 6.

7.

Pregnancy and Systemic Lupus Erythematosus.

Petri M.

Best Pract Res Clin Obstet Gynaecol. 2019 Oct 8. pii: S1521-6934(19)30133-6. doi: 10.1016/j.bpobgyn.2019.09.002. [Epub ahead of print] Review.

PMID:
31677989
8.

Differential Treatments Based on Drug-induced Gene Expression Signatures and Longitudinal Systemic Lupus Erythematosus Stratification.

Toro-Domínguez D, Lopez-Domínguez R, García Moreno A, Villatoro-García JA, Martorell-Marugán J, Goldman D, Petri M, Wojdyla D, Pons-Estel BA, Isenberg D, Morales-Montes de Oca G, Trejo-Zambrano MI, García González B, Rosetti F, Gómez-Martín D, Romero-Díaz J, Carmona-Sáez P, Alarcón-Riquelme ME.

Sci Rep. 2019 Oct 29;9(1):15502. doi: 10.1038/s41598-019-51616-9.

9.

Prediction of damage accrual in systemic lupus erythematosus using the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI).

Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin PR, Gladman DD, Urowitz MB, Bruce IN, Isenberg DA, Rahman A, Alarcón GS, Petri M, Khamashta MA, Dooley MA, Ramsey-Goldman R, Manzi S, Zoma AA, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, van Vollenhoven RF, Jonsen A, Nived O, Ramos-Casals M, Kamen DL, Kalunian KC, Jacobsen S, Peschken CA, Askanase A, Hanly JG.

Arthritis Rheumatol. 2019 Oct 21. doi: 10.1002/art.41144. [Epub ahead of print]

PMID:
31631584
10.

Reply to Letter to Editor: Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy.

Petri M, Li J, Magder LS, Goldman DW.

Arthritis Rheumatol. 2019 Oct 21. doi: 10.1002/art.41146. [Epub ahead of print]

PMID:
31631561
11.

Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus.

Enocsson H, Wirestam L, Dahle C, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Ginzler E, Alarcón GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma AA, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, van Vollenhoven RF, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken CA, Askanase A, Stoll T, Bruce IN, Wetterö J, Sjöwall C.

J Autoimmun. 2019 Oct 17:102340. doi: 10.1016/j.jaut.2019.102340. [Epub ahead of print]

12.

Economic evaluation of damage accrual in an international SLE inception cohort using a multi-state model approach.

Barber MRW, Hanly JG, Su L, Urowitz MB, St Pierre Y, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin PR, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Farewell V, Stoll T, Buyon J, Clarke AE.

Arthritis Care Res (Hoboken). 2019 Oct 14. doi: 10.1002/acr.24092. [Epub ahead of print]

PMID:
31609532
13.

SLE Plasma Profiling Identifies Unique Signatures of Lupus Nephritis and Discoid Lupus.

Smith MA, Henault J, Karnell JL, Parker ML, Riggs JM, Sinibaldi D, Taylor DK, Ettinger R, Grant EP, Sanjuan MA, Kolbeck R, Petri MA, Casey KA.

Sci Rep. 2019 Oct 8;9(1):14433. doi: 10.1038/s41598-019-50231-y.

14.

PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21.

Bocharnikov AV, Keegan J, Wacleche VS, Cao Y, Fonseka CY, Wang G, Muise ES, Zhang KX, Arazi A, Keras G, Li ZJ, Qu Y, Gurish MF, Petri M, Buyon JP, Putterman C, Wofsy D, James JA, Guthridge JM, Diamond B, Anolik JH, Mackey MF, Alves SE, Nigrovic PA, Costenbader KH, Brenner MB, Lederer JA, Rao DA; Accelerating Medicines Partnership (AMP) RA/SLE Network.

JCI Insight. 2019 Oct 17;4(20). pii: 130062. doi: 10.1172/jci.insight.130062.

15.

Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy.

Petri M, Elkhalifa M, Li J, Magder LS, Goldman DW.

Arthritis Rheumatol. 2019 Sep 18. doi: 10.1002/art.41121. [Epub ahead of print]

PMID:
31532077
16.

Time to Lupus Low Disease Activity State in the Hopkins Lupus Cohort: Role of African-American Ethnicity.

Babaoglu H, Li J, Goldman D, Magder LS, Petri M.

Arthritis Care Res (Hoboken). 2019 Sep 10. doi: 10.1002/acr.24063. [Epub ahead of print]

PMID:
31507071
17.

The Accelerating Medicines Partnership - Organizational Structure and Preliminary Data from the Phase 1 Studies of Lupus Nephritis.

Hoover P, Der E, Berthier CC, Arazi A, Lederer JA, James JA, Buyon J, Petri M, Belmont HM, Izmirly P, Wofsy D, Hacohen N, Diamond B, Putterman C, Davidson A.

Arthritis Care Res (Hoboken). 2019 Sep 9. doi: 10.1002/acr.24066. [Epub ahead of print] Review.

PMID:
31502417
18.

Human Lupus Plasma Pro-Atherogenic Effects on Cultured Macrophages Are Not Mitigated by Statin Therapy: A Mechanistic LAPS Substudy.

Reiss AB, Arain HA, Kasselman LJ, Renna HA, Zhen J, Voloshyna I, DeLeon J, Carsons SE, Petri M.

Medicina (Kaunas). 2019 Aug 21;55(9). pii: E514. doi: 10.3390/medicina55090514.

19.

Assessment of Nonradioactive Multispectral Optoacoustic Tomographic Imaging With Conventional Lymphoscintigraphic Imaging for Sentinel Lymph Node Biopsy in Melanoma.

Stoffels I, Jansen P, Petri M, Goerdt L, Brinker TJ, Griewank KG, Poeppel TD, Schadendorf D, Klode J.

JAMA Netw Open. 2019 Aug 2;2(8):e199020. doi: 10.1001/jamanetworkopen.2019.9020.

20.

Publisher Correction: The immune cell landscape in kidneys of patients with lupus nephritis.

Arazi A, Rao DA, Berthier CC, Davidson A, Liu Y, Hoover PJ, Chicoine A, Eisenhaure TM, Jonsson AH, Li S, Lieb DJ, Zhang F, Slowikowski K, Browne EP, Noma A, Sutherby D, Steelman S, Smilek DE, Tosta P, Apruzzese W, Massarotti E, Dall'Era M, Park M, Kamen DL, Furie RA, Payan-Schober F, Pendergraft WF 3rd, McInnis EA, Buyon JP, Petri MA, Putterman C, Kalunian KC, Woodle ES, Lederer JA, Hildeman DA, Nusbaum C, Raychaudhuri S, Kretzler M, Anolik JH, Brenner MB, Wofsy D, Hacohen N, Diamond B; Accelerating Medicines Partnership in SLE network.

Nat Immunol. 2019 Oct;20(10):1404. doi: 10.1038/s41590-019-0473-3.

PMID:
31409923
21.

Correction to: Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis.

Qin L, Stanley S, Ding H, Zhang T, Truong VTT, Celhar T, Fairhurst AM, Pedroza C, Petri M, Saxena R, Mohan C.

Arthritis Res Ther. 2019 Aug 7;21(1):185. doi: 10.1186/s13075-019-1966-z.

22.

Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.

Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Steinsson K, Ramsey-Goldman R, Zoma AA, Manzi S, Nived O, Jonsen A, Khamashta MA, Alarcón GS, Svenungsson E, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Ramos-Casals M, Lim SS, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Theriault C, Farewell V.

Arthritis Rheumatol. 2019 Aug 7. doi: 10.1002/art.41070. [Epub ahead of print]

PMID:
31390162
23.

Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository.

Efthymiou M, Mackie IJ, Lane PJ, Andrade D, Willis R, Erkan D, Sciascia S, Krillis S, Bison E, Borges Galhardo Vendramini M, Romay-Penabad Z, Qi M, Tektonidou M, Ugarte A, Chighizola C, Belmont HM, Aguirre MA, Ji L, Branch DW, de Jesus G, Fortin PR, Andreoli L, Petri M, Cervera R, Rodriguez E, Knight JS, Atsumi T, Vega J, Sevim E, Bertolaccini ML, Pengo V, Cohen H; APS ACTION.

J Thromb Haemost. 2019 Dec;17(12):2069-2080. doi: 10.1111/jth.14596. Epub 2019 Sep 8.

PMID:
31364274
24.

Urinary pro-thrombotic, anti-thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis.

Qin L, Stanley S, Ding H, Zhang T, Truong VTT, Celhar T, Fairhurst AM, Pedroza C, Petri M, Saxena R, Mohan C.

Arthritis Res Ther. 2019 Jul 18;21(1):176. doi: 10.1186/s13075-019-1959-y. Erratum in: Arthritis Res Ther. 2019 Aug 7;21(1):185.

25.

Low hydroxychloroquine blood levels in patients who have had gastric bypass surgery.

Thomas DE, Lyons JS, Greene BS, Petri MA.

Lupus Sci Med. 2019 Jun 16;6(1):e000335. doi: 10.1136/lupus-2019-000335. eCollection 2019.

26.

The immune cell landscape in kidneys of patients with lupus nephritis.

Arazi A, Rao DA, Berthier CC, Davidson A, Liu Y, Hoover PJ, Chicoine A, Eisenhaure TM, Jonsson AH, Li S, Lieb DJ, Zhang F, Slowikowski K, Browne EP, Noma A, Sutherby D, Steelman S, Smilek DE, Tosta P, Apruzzese W, Massarotti E, Dall'Era M, Park M, Kamen DL, Furie RA, Payan-Schober F, Pendergraft WF 3rd, McInnis EA, Buyon JP, Petri MA, Putterman C, Kalunian KC, Woodle ES, Lederer JA, Hildeman DA, Nusbaum C, Raychaudhuri S, Kretzler M, Anolik JH, Brenner MB, Wofsy D, Hacohen N, Diamond B; Accelerating Medicines Partnership in SLE network.

Nat Immunol. 2019 Jul;20(7):902-914. doi: 10.1038/s41590-019-0398-x. Epub 2019 Jun 17. Erratum in: Nat Immunol. 2019 Aug 13;:.

PMID:
31209404
27.

Blood Pressure Variability and Age-related Blood Pressure Patterns in Systemic Lupus Erythematosus.

Stojan G, Magder LS, Petri M.

J Rheumatol. 2019 Jun 15. pii: jrheum.181131. doi: 10.3899/jrheum.181131. [Epub ahead of print]

PMID:
31203220
28.

Management strategies and future directions for systemic lupus erythematosus in adults.

Durcan L, O'Dwyer T, Petri M.

Lancet. 2019 Jun 8;393(10188):2332-2343. doi: 10.1016/S0140-6736(19)30237-5. Epub 2019 Jun 6. Review.

PMID:
31180030
29.

Platelet-bound C4d, low C3 and lupus anticoagulant associate with thrombosis in SLE.

Petri MA, Conklin J, O'Malley T, Dervieux T.

Lupus Sci Med. 2019 Mar 30;6(1):e000318. doi: 10.1136/lupus-2019-000318. eCollection 2019.

30.
31.

The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.

Radin M, Sciascia S, Erkan D, Pengo V, Tektonidou MG, Ugarte A, Meroni P, Ji L, Belmont HM, Cohen H, Ramires de Jesús G, Branch DW, Fortin PR, Andreoli L, Petri M, Rodriguez E, Rodriguez-Pinto I, Knight JS, Atsumi T, Willis R, Gonzalez E, Lopez-Pedrera R, Rossi Gandara AP, Borges Gualhardo Vendramini M, Banzato A, Sevim E, Barbhaiya M, Efthymiou M, Mackie I, Bertolaccini ML, Andrade D; APS ACTION.

Semin Arthritis Rheum. 2019 Dec;49(3):464-468. doi: 10.1016/j.semarthrit.2019.04.009. Epub 2019 May 2.

PMID:
31153708
32.

Pericarditis in Lupus.

Dein E, Douglas H, Petri M, Law G, Timlin H.

Cureus. 2019 Mar 1;11(3):e4166. doi: 10.7759/cureus.4166. Review.

33.

Letter in response to the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis et al.

Costedoat-Chalumeau N, Isenberg D, Petri M.

Ann Rheum Dis. 2019 May 2. pii: annrheumdis-2019-215573. doi: 10.1136/annrheumdis-2019-215573. [Epub ahead of print] No abstract available.

PMID:
31048291
34.

Construction of a Frailty Index as a Novel Health Measure in Systemic Lupus Erythematosus.

Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin P, Gladman DD, Urowitz MB, Bruce IN, Isenberg DA, Rahman A, Alarcón GS, Petri M, Khamashta MA, Dooley MA, Ramsey-Goldman R, Manzi S, Zoma AA, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, van Vollenhoven RF, Jonsen A, Nived O, Ramos-Casals M, Kamen DL, Kalunian KC, Jacobsen S, Peschken CA, Askanase A, Hanly JG.

J Rheumatol. 2019 Apr 15. pii: jrheum.181338. doi: 10.3899/jrheum.181338. [Epub ahead of print]

PMID:
30988130
35.

Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy.

Hong S, Banchereau R, Maslow BL, Guerra MM, Cardenas J, Baisch J, Branch DW, Porter TF, Sawitzke A, Laskin CA, Buyon JP, Merrill J, Sammaritano LR, Petri M, Gatewood E, Cepika AM, Ohouo M, Obermoser G, Anguiano E, Kim TW, Nulsen J, Nehar-Belaid D, Blankenship D, Turner J, Banchereau J, Salmon JE, Pascual V.

J Exp Med. 2019 May 6;216(5):1154-1169. doi: 10.1084/jem.20190185. Epub 2019 Apr 8.

36.

The prognostic value of sentinel lymph nodes on distant metastasis-free survival in patients with high-risk squamous cell carcinoma.

Jansen P, Petri M, Merz SF, Brinker TJ, Schadendorf D, Stang A, Stoffels I, Klode J.

Eur J Cancer. 2019 Apr;111:107-115. doi: 10.1016/j.ejca.2019.02.004. Epub 2019 Mar 5.

PMID:
30849684
37.

Abiotic transformation products of tetracycline and chlortetracycline in salt solutions and manure.

Keßler DN, Fokuhl VK, Petri MS, Spielmeyer A.

Chemosphere. 2019 Jun;224:487-493. doi: 10.1016/j.chemosphere.2019.02.169. Epub 2019 Feb 25.

PMID:
30831500
38.

First Spectroscopy of the Near Drip-line Nucleus ^{40}Mg.

Crawford HL, Fallon P, Macchiavelli AO, Doornenbal P, Aoi N, Browne F, Campbell CM, Chen S, Clark RM, Cortés ML, Cromaz M, Ideguchi E, Jones MD, Kanungo R, MacCormick M, Momiyama S, Murray I, Niikura M, Paschalis S, Petri M, Sakurai H, Salathe M, Schrock P, Steppenbeck D, Takeuchi S, Tanaka YK, Taniuchi R, Wang H, Wimmer K.

Phys Rev Lett. 2019 Feb 8;122(5):052501. doi: 10.1103/PhysRevLett.122.052501.

39.

Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus.

Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin P, Gladman DD, Urowitz MB, Bruce IN, Isenberg DA, Rahman A, Alarcón GS, Petri M, Khamashta MA, Dooley MA, Ramsey-Goldman R, Manzi S, Steinsson K, Zoma AA, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, van Vollenhoven RF, Jonsen A, Nived O, Ramos-Casals M, Kamen DL, Kalunian KC, Jacobsen S, Peschken CA, Askanase A, Hanly JG.

Arthritis Rheumatol. 2019 Aug;71(8):1297-1307. doi: 10.1002/art.40859. Epub 2019 May 29.

PMID:
30771242
40.

Safety and Efficacy of Belimumab Plus Standard Therapy for Up to Thirteen Years in Patients With Systemic Lupus Erythematosus.

Wallace DJ, Ginzler EM, Merrill JT, Furie RA, Stohl W, Chatham WW, Weinstein A, McKay JD, McCune WJ, Petri M, Fettiplace J, Roth DA, Ji B, Heath A.

Arthritis Rheumatol. 2019 Jul;71(7):1125-1134. doi: 10.1002/art.40861. Epub 2019 Jun 5.

41.

Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen.

Mendel A, Bernatsky S, Pineau CA, St-Pierre Y, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Wallace DJ, Merrill JT, Buyon J, Isenberg DA, Rahman A, Ginzler EM, Petri M, Dooley MA, Fortin P, Gladman DD, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón G, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Sanchez-Guerrero J, Bruce IN, Costedoat-Chalumeau N, Vinet E.

Rheumatology (Oxford). 2019 Jul 1;58(7):1259-1267. doi: 10.1093/rheumatology/kez014.

PMID:
30753683
42.

Fatigue Measurements in Systemic Lupus Erythematosus.

Barbacki A, Petri M, Aviña-Zubieta A, Alarcón GS, Bernatsky S.

J Rheumatol. 2019 Nov;46(11):1470-1477. doi: 10.3899/jrheum.180831. Epub 2019 Feb 1.

PMID:
30709953
43.

The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis.

Sciascia S, Willis R, Pengo V, Krilis S, Andrade D, Tektonidou MG, Ugarte A, Chighizola C, Branch DW, Levy RA, Nalli C, Fortin PR, Petri M, Rodriguez E, Rodriguez-Pinto I, Atsumi T, Nascimento I, Rosa R, Banzato A, Erkan D, Cohen H, Efthymiou M, Mackie I, Bertolaccini ML; APS ACTION.

Thromb Res. 2019 Mar;175:32-36. doi: 10.1016/j.thromres.2019.01.010. Epub 2019 Jan 18.

PMID:
30685523
44.

Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.

Wirestam L, Enocsson H, Skogh T, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace D, Isenberg DA, Rahman A, Merrill J, Ginzler E, Alarcón GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma A, Ruiz-Irastorza G, Lim S, Kalunian K, Inanc M, van Vollenhoven R, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken C, Askanase A, Stoll T, Bruce IN, Wetterö J, Sjöwall C.

J Rheumatol. 2019 May;46(5):492-500. doi: 10.3899/jrheum.180713. Epub 2019 Jan 15.

45.

Enhanced Electric Dipole Strength for the Weakly Bound States in ^{27}Ne.

Loelius C, Kobayashi N, Iwasaki H, Bazin D, Belarge J, Bender PC, Brown BA, Elder R, Elman B, Gade A, Grinder M, Heil S, Hufnagel A, Longfellow B, Lunderberg E, Mathy M, Otsuka T, Petri M, Syndikus I, Tsunoda N, Weisshaar D, Whitmore K.

Phys Rev Lett. 2018 Dec 28;121(26):262501. doi: 10.1103/PhysRevLett.121.262501.

PMID:
30636164
46.

Association between changes in gene signatures expression and disease activity among patients with systemic lupus erythematosus.

Petri M, Fu W, Ranger A, Allaire N, Cullen P, Magder LS, Zhang Y.

BMC Med Genomics. 2019 Jan 9;12(1):4. doi: 10.1186/s12920-018-0468-1.

47.

Resolution of Inflammation Through the Lipoxin and ALX/FPR2 Receptor Pathway Protects Against Abdominal Aortic Aneurysms.

Petri MH, Thul S, Andonova T, Lindquist-Liljeqvist M, Jin H, Skenteris NT, Arnardottir H, Maegdefessel L, Caidahl K, Perretti M, Roy J, Bäck M.

JACC Basic Transl Sci. 2018 Dec 31;3(6):719-727. doi: 10.1016/j.jacbts.2018.08.005. eCollection 2018 Dec.

48.

Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort.

Mendel A, Bernatsky SB, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Wallace DJ, Merrill JT, Buyon JP, Isenberg DA, Rahman A, Ginzler EM, Petri M, Dooley MA, Fortin PR, Gladman DD, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Sanchez-Guerrero J, Bruce IN, Costedoat-Chalumeau N, Vinet É.

Ann Rheum Dis. 2019 Jul;78(7):1010-1012. doi: 10.1136/annrheumdis-2018-214434. Epub 2018 Dec 20. No abstract available.

49.

Predictors of persistent disease activity and long quiescence in systemic lupus erythematosus: results from the Hopkins Lupus Cohort.

Giannakou I, Chatzidionysiou K, Magder LS, Györi N, van Vollenhoven R, Petri MA.

Lupus Sci Med. 2018 Nov 2;5(1):e000287. doi: 10.1136/lupus-2018-000287. eCollection 2018.

50.

Systemic lupus erythematosus: Diagnosis and clinical management.

Fava A, Petri M.

J Autoimmun. 2019 Jan;96:1-13. doi: 10.1016/j.jaut.2018.11.001. Epub 2018 Nov 16. Review.

PMID:
30448290

Supplemental Content

Support Center